CJC-1295 & Ipamorelin

What Is Ipamorelin? Sequence, Receptor and Selectivity

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-293 cited sources

The short answer

Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, at 711.9 Da. It acts at the ghrelin receptor and was described by Raun and colleagues in 1998 as the first selective growth hormone secretagogue. Selective here means it released GH without the cortisol and prolactin effects of earlier compounds.

Key facts

Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2
Residues
5, C-terminal amide
Molecular weight
711.9 Da
Formula
C38H49N9O5
CAS number
170851-70-4
PubChem CID
9831659
Development code
NNC 26-0161 (Novo Nordisk)
Target
Ghrelin receptor (GHS-R1a)

What selective meant

Raun and colleagues titled their 1998 paper in the European Journal of Endocrinology 'Ipamorelin, the first selective growth hormone secretagogue'. The selectivity claim is specific: earlier secretagogues released GH but also raised cortisol and prolactin, which confounds both research and any therapeutic use. Ipamorelin was reported to release GH without those accompanying effects.

The unusual residues

Only one of its five residues is an ordinary L-amino acid. Position 1 is α-aminoisobutyric acid (Aib), a non-proteinogenic residue with a quaternary alpha carbon. Positions 3 and 4 are D-amino acids: D-2-naphthylalanine and D-phenylalanine. Position 2 is histidine and position 5 lysine, with a C-terminal amide. This is a heavily engineered molecule rather than a natural sequence.

Research material referenced

CJC-1295 + Ipamorelin 5+5mg, third-party HPLC tested

Buy CJC-1295 + Ipamorelin · £42.99

Why Aib appears here and in semaglutide

This is a real cross-connection. Aib's quaternary alpha carbon makes adjacent bonds poor substrates for peptidases, which is why semaglutide carries Aib at position 8 to block DPP-4. Two entirely unrelated peptides, thirty years apart, reach for the same residue to solve the same problem: protease resistance in a short peptide.

What D-amino acids do

Proteases evolved to cleave L-amino acid backbones and generally cannot process D-residues. Two D-residues in a five-residue peptide makes most of it enzymatically inaccessible. Combined with Aib and the C-terminal amide, which blocks carboxypeptidases, nearly every position is protected. The peptide is short because it does not need length to survive.

The ghrelin receptor

Ipamorelin acts at the growth hormone secretagogue receptor GHS-R1a, whose endogenous ligand is ghrelin. That is a different pathway from CJC-1295's, which acts at the GHRH receptor. Both converge on pituitary GH release, which is the basis for studying them together.

Regulatory position

Ipamorelin holds no marketing authorisation from the MHRA, EMA or FDA. Growth hormone secretagogues are prohibited in sport under the WADA list. It is supplied here for laboratory research only.

Frequently asked questions

What does selective mean for ipamorelin?

That it released GH without the cortisol and prolactin increases seen with earlier secretagogues, the specific claim in Raun's 1998 paper title.

What is Aib?

α-aminoisobutyric acid, a non-proteinogenic residue whose quaternary alpha carbon blocks peptidase access. It is the same residue semaglutide uses to block DPP-4.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More CJC-1295 & Ipamorelin articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.